The Role of Cancer Stem Cells in the Organ Tropism of Breast Cancer Metastasis: A Mechanistic Balance between the “Seed” and the “Soil”?
Open Access
- 1 January 2012
- journal article
- Published by Hindawi Limited in International Journal of Breast Cancer
- Vol. 2012, 1-12
- https://doi.org/10.1155/2012/209748
Abstract
Breast cancer is a prevalent disease worldwide, and the majority of deaths occur due to metastatic disease. Clinical studies have identified a specific pattern for the metastatic spread of breast cancer, termed organ tropism; where preferential secondary sites include lymph node, bone, brain, lung, and liver. A rare subpopulation of tumor cells, the cancer stem cells (CSCs), has been hypothesized to be responsible for metastatic disease and therapy resistance. Current treatments are highly ineffective against metastatic breast cancer, likely due to the innate therapy resistance of CSCs and the complex interactions that occur between cancer cells and their metastatic microenvironments. A better understanding of these interactions is essential for the development of novel therapeutic targets for metastatic disease. This paper summarizes the characteristics of breast CSCs and their potential metastatic microenvironments. Furthermore, it raises the question of the existence of a CSC niche and highlights areas for future investigation.Keywords
Funding Information
- Ontario Institute of Cancer Research (08NOV230, 13199)
This publication has 99 references indexed in Scilit:
- In vitro generation of human cells with cancer stem cell propertiesNature, 2011
- Dynamics between Stem Cells, Niche, and Progeny in the Hair FollicleCell, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Targeting breast cancer stem cellsMolecular Oncology, 2010
- TGFβ in CancerCell, 2008
- Bone Marrow Microenvironment and Tumor ProgressionCancer Microenvironment, 2008
- Isolation of rare circulating tumour cells in cancer patients by microchip technologyNature, 2007
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Breast Cancer Metastasis to the Central Nervous SystemThe American Journal of Pathology, 2005
- Multistep Nature of Metastatic Inefficiency: Dormancy of Solitary Cells after Successful Extravasation and Limited Survival of Early MicrometastasesThe American Journal of Pathology, 1998